High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines
Human papillomavirus (HPV) is detected in 99.7% of cervical cancers. Current vaccines target types 16 and 18. Prior to vaccination implementation, a prospective cohort study was conducted to determine baseline HPV prevalence in unvaccinated women in Wales; after HPV16 and HPV18, HPV 51 was found to...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-10-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/10/10/1754 |
| _version_ | 1827647743206621184 |
|---|---|
| author | Sarah J. Bowden Laura Burney Ellis Maria Kyrgiou Alison N. Fiander Samantha Hibbitts |
| author_facet | Sarah J. Bowden Laura Burney Ellis Maria Kyrgiou Alison N. Fiander Samantha Hibbitts |
| author_sort | Sarah J. Bowden |
| collection | DOAJ |
| description | Human papillomavirus (HPV) is detected in 99.7% of cervical cancers. Current vaccines target types 16 and 18. Prior to vaccination implementation, a prospective cohort study was conducted to determine baseline HPV prevalence in unvaccinated women in Wales; after HPV16 and HPV18, HPV 51 was found to be most prevalent. This study aimed to re-assess the unexpected high prevalence of HPV 51 and consider its potential for type-replacement. Two hundred HPV 51 positive samples underwent re-analysis by repeating the original methodology using HPV 51 GP5+/6+ PCR-enzyme immunoassay, and additionally a novel assay of HPV 51 E7 PCR. Data were correlated with age, social deprivation and cytology. Direct repeat of HPV 51 PCR-EIA identified 146/195 (75.0%) samples as HPV 51 positive; E7 PCR identified 166/195 (85.1%) samples as HPV 51 positive. HPV 51 prevalence increased with cytological grade. The prevalence of HPV 51 in the pre-vaccinated population was truly high. E7 DNA assays may offer increased specificity for HPV genotyping. Cross-protection of current vaccines against less-prevalent HPV types warrants further study. This study highlights the need for longitudinal investigation into the prevalence of non-vaccine HPV types, especially those phylogenetically different to vaccine types for potential type-replacement. Ongoing surveillance will inform future vaccines. |
| first_indexed | 2024-03-09T19:23:52Z |
| format | Article |
| id | doaj.art-4bdf283f71614bc6a96ddfe199716e4e |
| institution | Directory Open Access Journal |
| issn | 2076-393X |
| language | English |
| last_indexed | 2024-03-09T19:23:52Z |
| publishDate | 2022-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj.art-4bdf283f71614bc6a96ddfe199716e4e2023-11-24T03:05:30ZengMDPI AGVaccines2076-393X2022-10-011010175410.3390/vaccines10101754High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV VaccinesSarah J. Bowden0Laura Burney Ellis1Maria Kyrgiou2Alison N. Fiander3Samantha Hibbitts4IRDB, Imperial College London, London W12 0NN, UKIRDB, Imperial College London, London W12 0NN, UKIRDB, Imperial College London, London W12 0NN, UKSchool of Medicine, Cardiff University, Cardiff CF14 4XN, UKSchool of Medicine, Cardiff University, Cardiff CF14 4XN, UKHuman papillomavirus (HPV) is detected in 99.7% of cervical cancers. Current vaccines target types 16 and 18. Prior to vaccination implementation, a prospective cohort study was conducted to determine baseline HPV prevalence in unvaccinated women in Wales; after HPV16 and HPV18, HPV 51 was found to be most prevalent. This study aimed to re-assess the unexpected high prevalence of HPV 51 and consider its potential for type-replacement. Two hundred HPV 51 positive samples underwent re-analysis by repeating the original methodology using HPV 51 GP5+/6+ PCR-enzyme immunoassay, and additionally a novel assay of HPV 51 E7 PCR. Data were correlated with age, social deprivation and cytology. Direct repeat of HPV 51 PCR-EIA identified 146/195 (75.0%) samples as HPV 51 positive; E7 PCR identified 166/195 (85.1%) samples as HPV 51 positive. HPV 51 prevalence increased with cytological grade. The prevalence of HPV 51 in the pre-vaccinated population was truly high. E7 DNA assays may offer increased specificity for HPV genotyping. Cross-protection of current vaccines against less-prevalent HPV types warrants further study. This study highlights the need for longitudinal investigation into the prevalence of non-vaccine HPV types, especially those phylogenetically different to vaccine types for potential type-replacement. Ongoing surveillance will inform future vaccines.https://www.mdpi.com/2076-393X/10/10/1754HPVhuman papillomavirusvaccinetype-replacementcervicalcross-protection |
| spellingShingle | Sarah J. Bowden Laura Burney Ellis Maria Kyrgiou Alison N. Fiander Samantha Hibbitts High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines Vaccines HPV human papillomavirus vaccine type-replacement cervical cross-protection |
| title | High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines |
| title_full | High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines |
| title_fullStr | High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines |
| title_full_unstemmed | High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines |
| title_short | High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines |
| title_sort | high prevalence of hpv 51 in an unvaccinated population and implications for hpv vaccines |
| topic | HPV human papillomavirus vaccine type-replacement cervical cross-protection |
| url | https://www.mdpi.com/2076-393X/10/10/1754 |
| work_keys_str_mv | AT sarahjbowden highprevalenceofhpv51inanunvaccinatedpopulationandimplicationsforhpvvaccines AT lauraburneyellis highprevalenceofhpv51inanunvaccinatedpopulationandimplicationsforhpvvaccines AT mariakyrgiou highprevalenceofhpv51inanunvaccinatedpopulationandimplicationsforhpvvaccines AT alisonnfiander highprevalenceofhpv51inanunvaccinatedpopulationandimplicationsforhpvvaccines AT samanthahibbitts highprevalenceofhpv51inanunvaccinatedpopulationandimplicationsforhpvvaccines |